Search
28 Apr COTA Aims to Deliver Best Quality Care at Best Price
MedicalResearch.com Interview with: Andrew L. Pecora, M.D., F.A.C.P., C.P.E. COTA Founder and Executive Chairman Chief Innovations Officer and Vice President of Cancer Services at Hackensack University Medical Center Background: Key leadership of health care informatics company, COTA, Inc., will travel to Vatican City after being invited to speak at The Vatican’s Third International...25 Apr Biomarker Defines Subgroup of HER2-positive Breast Cancers Resistant to Herceptin
MedicalResearch.com Interview with: Sherene Loi, MBBS(Hons), FRACP, PhD Associate Professor, University of Melbourne Consultant Medical Oncologist, Breast Unit Head, Translatonal Breast Cancer Genomics and Therapeutics Lab Cancer Council Victoria John Colebatch Fellow Peter MacCallum Cancer Centre, East Melbourne Victoria, Australia MedicalResearch.com: What is the background for this study? What are...22 Apr Paradoxical Cell Death Mechanism Accelerates Pancreatic Cancer Growth
MedicalResearch.com Interview with: Dr. George Miller, MD Vice Chair for research, Department of Surgery Associate Professor, Department of Surgery Associate Professor, Department of Cell Biology NYU Langone’s Perlmutter Cancer Center MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Miller: Cancer cell death is the...22 Apr Females Tolerate Ischemia After Kidney Transplantion Better Than Males
Posted at 15:24h
in Author Interviews, Gender Differences, Kidney Disease, Transplantation, University of Pennsylvania
MedicalResearch.com Interview with: Matthew Levine, MD, PhD Assistant Professor of Transplant Surgery Perelman School of Medicine University of Pennsylvania MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Levine: This work stemmed from a known finding that female mice tolerate kidney injury better than males and...
22 Apr Advanced colorectal cancer still has a poor prognosis and more active drugs are urgently needed
MedicalResearch.com Interview with: Silvia Marsoni, M.D. Director Clinical Research Office FPO – Istituto di Candiolo IRCCS Institute for Cancer Research @ Candiolo 10060 Candiolo (TO) – Italy MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Marsoni: In the Lancet Oncology of April 20 2016,...21 Apr Biomarker Expression Linked to Aggressive Basal Cell Skin Cancer
MedicalResearch.com Interview with: Alon Kahana, MD, PhD Associate Professor Kellogg Eye Center University of Michigan MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Kahana: Basal cell carcinoma is the most common cancer – more common than all other cancers combined. Fortunately, it is usually...20 Apr Study Evaluates Obesity-Related Factors Leading to Pancreatic Cancer Progression
MedicalResearch.com Interview with: Joao Incio MD Research Fellow in Radiation Oncology Harvard Medical School/MGH Boston, MA MedicalResearch.com: What is the background for this study? Dr. Incio: With the current epidemic of obesity, the majority of pancreatic cancer patients are overweight or obese at diagnosis. Importantly, obesity worsens treatment outcomes in...19 Apr Good Overall Agreement Among Three PD-L1 Diagnostic Assays
MedicalResearch.com Interview with: Marianne J. Ratcliffe, PhD Associate director of diagnostics AstraZeneca Alderley Park, UK MedicalResearch.com: What is the background for this study? Dr. Ratcliffe: PD-L1 status is informative when considering monotherapy treatment and of growing importance when we consider that treatment decision will, in the near future also include...15 Apr Hepatitis C Raises Risk of HPV Head and Neck Cancers
Posted at 02:16h
in Author Interviews, Cancer Research, Hepatitis - Liver Disease, HPV, JNCI, MD Anderson
MedicalResearch.com Interview with: Harrys A. Torres, MD, FACP, FIDSA Associate Professor Director of Hepatitis C Clinic Department of Infectious Diseases, Infection Control and Employee Health The University of Texas MD Anderson Cancer Center Houston TX 77030 Medical Research: What is the background for this study? What are the main findings?...
08 Apr Carefully Chosen Liquid Biopsy Can Detect and Monitor Lung Cancer Mutations
MedicalResearch.com Interview with: Adrian G. Sacher, M.D. Assistant Professor of Medicine Thoracic Oncology & Phase I Drug Development Columbia University/New York-Presbyterian Hospital MedicalResearch.com: What is the background for this study? Dr. Sacher: The aim of this prospective study was to determine the accuracy, turnaround time and robustness of ddPCR-based liquid...08 Apr Humanized Antibody Romosozumab May Increase Bone Mass In Resistant Osteoporosis Patients
MedicalResearch.com Interview with: Bente Langdahl Professor, Consultant, PhD, DMSc Department of Endocrinology and Internal Medicine THG Aarhus University Hospital Aarhus Denmark MedicalResearch.com: What is the background for this study? What are the main findings? Response: Romosozumab is a humanised antibody against sclerostin currently in development for the treatment of osteoporosis....06 Apr Dual Treatment Strategies Can Slow Glioblastoma Tumor Growth
Posted at 17:24h
in Author Interviews, Brain Cancer - Brain Tumors, Brigham & Women's - Harvard, PNAS
MedicalResearch.com Interview with: Rakesh K. Jain, Ph.D. A.W.Cook Professor of Radiation Oncology (Tumor Biology) Director, E.L. Steele Laboratory Department of Radiation Oncology Harvard Medical School and Massachusetts General Hospital Boston, MA 02114 MedicalResearch.com: What is glioblastoma and why is it difficult to treat? Dr. Jain: Glioblastoma (GBM) is the...
06 Apr Switching from Sitagliptin to Liraglutide Can Control Hyperglyciemia in Some With Type 2 Diabetes
MedicalResearch.com Interview with: Dr. Maximo Maislos MD Head of the Atherosclerosis and Metabolism Unit Department of Medicine of the Soroka University Medical Center Israel MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Maislos: When diet and exercise are insufficient, Type 2 Diabetes Mellitus patients...05 Apr New Combination Drug for Heart Failure Likely To Be Cost-Effective But Not Cost Saving
MedicalResearch.com Interview with: Dr. Jordan B. King Post Doctoral Fellow Pharmacotherapy Outcome Resctr, University of Utah MedicalResearch.com: What is the background for this study? What are the main findings? Response: The cornerstone of treatment in heart failure with reduced ejection fraction (HFrEF) revolves around low-cost generic medications such as angiotensin...04 Apr QRS Duration May Identify High Risk Heart Failure with Preserved Ejection Fraction Patients
MedicalResearch.com Interview with: Jacob Joseph, MD, FACC, FAHA Associate Professor of Medicine, Harvard Medical School Cardiology Consortium Lead, VA Clinical Trial Network, Associate Physician, Brigham & Women’s Hospital MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Joseph: The background for this study is the...01 Apr Patients Take Only Little More Than Half Prescribed Antibiotic After leaving Hospital For Skin Infections
MedicalResearch.com Interview with: Loren G. Miller, M.D., M.P.H. Professor of Medicine, David Geffen School of Medicine at UCLA Division of Infectious Diseases Los Angeles BioMedical Research Institute at Harbor-UCLA Torrance CA 90502 MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Miller: We know that...31 Mar Complement Inhibitor Reverses Periodontitis
MedicalResearch.com Interview with: George Hajishengallis, D.D.S., Ph.D., Thomas W. Evans Centennial Professor University of Pennsylvania Penn Dental Medicine – Microbiology Philadelphia, PA 19104-6030 MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Hajishengallis: The current study is the result of eight years of collaboration with...30 Mar PSA Screening Must Be Used Conservatively To Be Cost-Effective
MedicalResearch.com Interview with: Joshua A. Roth, PhD, MHA Assistant Member AHRQ Patient-Centered Outcomes Research K12 Scholar Hutchinson Institute for Cancer Outcomes Research MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Roth: PSA prostate cancer screening is controversial because of uncertainty about the overall benefit-risk...27 Mar Over 40% of Transgender Young Women Have Substance Dependence or Mental Health Issues
Posted at 14:59h
in Addiction, Author Interviews, Brigham & Women's - Harvard, Gender Differences, JAMA, Sexual Health
MedicalResearch.com Interview with: Dr. Sari L. Reisner PhD Research Fellow in the Department of Epidemiology Harvard T.H. Chan School of Public Health Associate Scientific Researcher in the Division of General Pediatrics Boston Children’s Hospital/ Harvard Medical School MedicalResearch.com: What are the main findings? Dr. Reisner: Transgender youth—including adolescent and young adult transgender...